Bionano Genomics, Inc. Revenue Disclosure
3. Revenue from Contracts with Customers
Revenue by Source
|
|
Years Ended December 31, |
|
|||||
|
|
2025 |
|
|
2024 |
|
||
Instruments |
|
$ |
6,363,000 |
|
|
$ |
8,043,000 |
|
Consumables |
|
|
13,970,000 |
|
|
|
12,773,000 |
|
Software |
|
|
6,410,000 |
|
|
|
6,192,000 |
|
Total product revenue |
|
|
26,743,000 |
|
|
|
27,008,000 |
|
Services and other |
|
|
1,765,000 |
|
|
|
3,768,000 |
|
Total revenue |
|
$ |
28,508,000 |
|
|
$ |
30,776,000 |
|
Revenue by Geographic Location
|
|
Years Ended December 31, |
|
|||||||||||||
|
|
2025 |
|
|
2024 |
|
||||||||||
|
|
$ |
|
|
% |
|
|
$ |
|
|
% |
|
||||
Americas |
|
$ |
12,180,000 |
|
|
|
42.7 |
% |
|
$ |
13,649,000 |
|
|
|
44.3 |
% |
EMEA |
|
|
14,108,000 |
|
|
|
49.5 |
% |
|
|
14,234,000 |
|
|
|
46.3 |
% |
Asia Pacific |
|
|
2,220,000 |
|
|
|
7.8 |
% |
|
|
2,893,000 |
|
|
|
9.4 |
% |
Total |
|
$ |
28,508,000 |
|
|
|
100 |
% |
|
$ |
30,776,000 |
|
|
|
100 |
% |
The tables above provide revenue from contracts with customers by source and geographic location (based on the customer’s billing address) on a disaggregated basis. Americas consists of North America and South America. EMEA consists of Europe, the Middle East and Africa. Asia Pacific includes China, Japan, South Korea, Singapore, India and Australia.
For the years ended December 31, 2025 and 2024, the United States represented 37% and 36% of total revenue, respectively. No other countries represented greater than 10% of total revenue during the years ended December 31, 2025 and 2024.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 23, 2026 | Showing above |
| 2024 | Mar 31, 2025 | |
| 2023 | Mar 5, 2024 | |
| 2022 | Mar 9, 2023 | |
| 2021 | Mar 1, 2022 | |
About Revenue Disclosures
Revenue disclosures under ASC 606 explain how a company identifies performance obligations, allocates transaction prices, and determines when revenue is recognized. This section is essential for understanding whether reported revenue reflects genuine economic activity or aggressive accounting choices. Analysts examine the mix of point-in-time versus over-time recognition, which directly affects revenue timing and comparability.
Key signals: rising contract liabilities (deferred revenue) suggest strong future revenue visibility, while declining contract assets may indicate slowing project milestones. Watch for variable consideration estimates — rebates, returns, and performance bonuses that require management judgment. Significant changes in disaggregated revenue by geography or product line can reveal shifting business mix before it appears in headline numbers. Compare revenue growth against contract liability growth to assess sustainability, and scrutinize any changes in the timing of recognition that coincide with earnings pressure.